M-End DMX and Moxetumomab Pasudotox-tdfk
Determining the interaction of M-End DMX and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexbrompheniramine / dextromethorphan / pseudoephedrine
Brand name: M-End DMX
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- M-End DMX-Moxetumomab pasudotox-tdfk Intravenous
- M-End DMX-Moxifloxacin
- M-End DMX-Moxifloxacin (Systemic)
- M-End DMX-Moxifloxacin Hydrochloride
- M-End DMX-Moxifloxacin Injection
- M-End DMX-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-M-End Max D
- Moxetumomab Pasudotox-tdfk-M-End PE
- Moxetumomab Pasudotox-tdfk-M-End WC
- Moxetumomab Pasudotox-tdfk-M-Hist DM
- Moxetumomab Pasudotox-tdfk-M-Hist PD
- Moxetumomab Pasudotox-tdfk-M-M-R II